Entry created on 1 July 2019 (Revision 1.0) Annotator: Rita Pancsa; Bálint Mészáros
Basic protein information
Accession Q92804
Common name TAF15
Gene TAF15
Organism Homo sapiens
Uniprot name TATA-binding protein-associated factor 2N
Basic LLPS information
Organelle nuclear protein granule
Type of experimental evidence
Protein region(s) mediating LLPS
1
-
180
N-terminal S/Y/Q/G-rich disordered domain
181
-
216
disordered RGG repeats
234
-
320
RNA binding region RRM
Based on the experimental results of the following publication: 26286827
Molecular features viewer
PDB structures
Extended LLPS information
Functional description
The intracellular environment is organized into membraneless compartments that have been termed biomolecular condensates because they form by liquid-liquid phase separation. These condensates often contain RNA binding proteins (RBPs) with distinctive domains, so-called prion-like domains, which are structurally disordered and contain polar amino acids. Interactions between prion-like domains and additional interactions between RNAs and RNA binding domains drive the assembly of prion-like RBPs by phase separation. Many of these phase separated granules are found inside the nucleus, and while their exact roles are not fully understood, many such organelles – for example those that are formed by EWS or TAF15 – are associated with genotoxic stress and can form in response to DNA damage (PMID:29650702 PMID:26286827).
Literature supporting the LLPS: 22454397, 24267890, 26286827, 29650702
Functional class of membraneless organelle: activation/nucleation/signal amplification/bioreactor; protective storage/reservoir
Binding partners (at biological protein concentrations)
1) poly(ADP-ribose) (drives LLPS nucleation in cells) 2) RNA (induces/inhibits droplet formation in low/high concentrations)
Type of RNA(s) required/used for the LLPS at biological protein concentrations
RNA not required.
Molecular interaction types contributing to LLPS
complex coacervation (PMID:26286827) prion-like aggregation (PMID:29961577) cation-π (cation-pi) interactions (PMID:29961577) π-π (pi-pi) interactions (PMID:29961577)
Determinants of phase separation and droplet properties
1) protein concentration of TAF15 2) concentration of poly(ADP-ribose) 3) RNA concentration
Membrane cluster No
Partner-dependent No
RNA-dependent No
PTM required No
Domain-motif interactions No
Discrete oligomerization No
Regulation and disease
Post-translational modifications affecting LLPS
Position Residue PTM Effect Reference Modifying enzyme Notes
Isoforms known to affect LLPS
Isoform Effect Reference
All known isoforms containing sequence changes in the LLPS region(s)
Position type Isoform names from UniProt
Disease mutations affecting LLPS
Mutation dbSNP Disease OMIM Effect Reference Notes
Experimental information
Experimental techniques applied to prove/investigate LLPS
FUS, EWSR1, and TAF15, which constitute the FET family showed robust phase separation in the absence of crowding agents at a protein concentration of 5 μM (PMID:29961577). In vivo expression of the protein in human cells, truncated to residues 1-216 (low complexity N-terminal region) led to assembly into structures with remarkably spherical morphology via liquid demixing, evidenced by GFP-tagging and fluorescence and phase-contrast microscopy. The RGG repeat region was shown to mediate poly(ADP-ribose) (PAR) binding, using in vivo expression of GFP-tagged full length protein with induced mutations in the RGG region. The number of RGG repeats determined the efficiency of PAR binding, co-localization with PAR, and hence, recruitment to sites of DNA damage. While this is not strictly required for LLPS, PAR binding serves as a nucleation event, increasing local protein concentration at sites of DNA damage. Protein localization and co-localization was followed using standard widefield, confocal, high-content microscopy and time-lapse imaging. In a cellular, in vivo context, depletion of TAF15 with RNA interference, and abrogation of PAR formation both led to the lack of granule formation at sites of DNA damage, observed using time-lapse bright-field and phase-contrast live-cell microscopy. In vitro cell-free measurements recombinant TAF15 was incubated with and without sub-stoichiometric amounts of PAR, forming spontaneous aggregates, which were consistently larger in the presence of PAR, followed by transmission electron microscopy (TEM). Consistent with in vivo results, these data provide evidence for the intrinsic ability of PAR chains to nucleate aggregation of low complexity domain-containing disordered proteins (PMID:26286827).
Experimental observations supporting the liquid material state of the condensate
morphological traits (PMID:26286827) reversibility of formation and dissolution (PMID:26286827)